PHARMACIES: Provides relative to pharmaceutical costs (OR +$153,127 GF EX See Note)
Read by title, under the rules, referred to the Committee on Health and Welfare.
Email me when HB 918 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 918. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill requires the Louisiana Department of Health to compile a list of critical prescription drugs and to collect detailed cost data from manufacturers. It forces manufacturers to report production, R&D, and marketing costs, and it mandates price disclosures in any marketing to providers. The goal is to give lawmakers and the public clearer insight into drug pricing and to curb excessive costs.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 918
3 free questions a day, no accountHistory
- Read by title, under the rules, referred to the Committee on Health and Welfare.
- Under the rules, provisionally referred to the Committee on Health and Welfare.
Sponsors
- Jay Gallé (R) · sponsor
- Jay Galle
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 918 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 918 freeOr ask your AI assistant about HB 918 directly:
Add to Claude, ChatGPT or Cursor